Nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma among patients with impaired renal function: defining predictors of outcomes

2015 ◽  
Vol 86 (1-2) ◽  
pp. 44-48 ◽  
Author(s):  
Kamran Zargar-Shoshtari ◽  
Kenan Ashouri ◽  
Pranav Sharma ◽  
Adam Baumgarten ◽  
Wade J. Sexton ◽  
...  
2021 ◽  
Author(s):  
Laura Horodyski ◽  
Javier Gonzalez ◽  
Marina M. Tabbara ◽  
Jeffrey J. Gaynor ◽  
Maria Rodriguez-Cabero ◽  
...  

Abstract Background It has been suggested that IVC reconstruction of retroperitoneal tumors is not required when adequate collateral circulation is present, though transient rise in creatinine may occur post-operatively. There are no reports evaluating mid- and long-term effect on renal function in these patients. The purpose of this study is to assess whether resection of a right renal cell carcinoma and inferior vena cava with obstructing tumor thrombus is safe to perform without reconstructing the inferior vena cava with regard to long-term renal function. Materials and Methods A bi-institutional retrospective review was performed over an 18 year period, assessing patients with right renal cell carcinoma and obstructing level II-IV tumor thrombus. Results Twenty-two patients were included in the study. Median age was 62.5 (range 45-79) years old and 19 (86%) of the patients were male. One patient (5%) had a level II thrombus, 14 patients (64%) had a level III thrombus (IIIa n=3, IIIb n=6, IIIc n= 3, IIId n=2), and seven patients (32%) had a level IV thrombus. Intra-operatively, median estimated blood loss was 1.35 (range 0.2 – 25) L. The median length of hospital stay was 11 (range 5 – 50) days. Median preoperative creatinine was 1.20 (range 0.40 – 2.70) mg/dL and postoperatively, median creatinine was 1.3 (range 0.86 – 2.20) mg/dL. Median creatinine at 6 month and 12 months follow-up was 1.10 (range 0.5 – 1.6) and mg/dL 1.34 (range 0.6 – 2.0), respectively. Eight patients were lost to follow-up, and two died (one in the hospital, and the other three months post-operatively). Conclusions Resection of right renal cell carcinoma with inferior vena cava in the presence of an obstructing level II- IV tumor thrombus without reconstruction of the inferior vena cava appears not to have a significant adverse effect on long-term renal function.


1983 ◽  
Vol 130 (4) ◽  
pp. 660-663 ◽  
Author(s):  
Pramod C. Sogani ◽  
Harry W. Herr ◽  
Manjit S. Bains ◽  
Willet F. Whitmore

2006 ◽  
Vol 21 (3) ◽  
pp. 304-306 ◽  
Author(s):  
Fernando A. Atik ◽  
Jose L. Navia ◽  
Venkatesh Krishnamurthi ◽  
Gurmeet Singh ◽  
Takahiro Shiota ◽  
...  

2017 ◽  
Vol 197 (4S) ◽  
Author(s):  
Yoshimi Tanaka ◽  
Yasuhiro Hashimoto ◽  
Shingo Hatakeyama ◽  
Shogo Hosogoe ◽  
Toshikazu Tanaka ◽  
...  

2018 ◽  
Vol 34 (5) ◽  
pp. 375-382
Author(s):  
Viyana Hamblen

Inferior vena cava (IVC) tumor thrombus in renal cell carcinoma is a rare entity that suggests heightened biologic behavior and a surgical challenge during the course of treatment. Tumor thrombus can extend from the renal vein to the right atrium. This cephalad extension is classified by four different levels. These levels determine which surgical approach is used, whether a thoracoabdominal incision is needed, and whether a patient needs to be placed in circulatory arrest. Complete surgical resection of the tumor is potentially the only curative treatment, although it supposes a challenge because of operative difficulty and the potential for massive bleeding or tumor pulmonary thromboembolism. IVC tumor thrombus presents with a few differentials that need to be assessed, including bland thrombus, primary IVC leiomyosarcoma, hepatocellular carcinoma, adrenal cortical carcinoma, primary lung carcinoma, and Wilms tumor. The importance of diagnosing IVC tumor thrombus secondary to renal cell carcinoma is demonstrated as well as a sonographic protocol for assessing IVC tumor thrombus.


Sign in / Sign up

Export Citation Format

Share Document